Gene,chr,Inheritance,Onset,Disease or Syndrome
AAAS,12q13.13,recessive,childhood,Achalasia-Addisonianism-Alacrimia (AAA) syndrom
AARS,16q22.1,dominant and recessive,6 to 54 years; infancy,CMTD2N; EIEE29
AARS2,6p21.1,recessive,early childhood,Combined Oxidative Phosphorylation Deficiency 8; Progressive Leukoencephalopathy with Ovarian Failure
ABCB7,Xq13.3,recessive,1 year,Sideroblastic Anemia with Ataxia
ABCD1,Xq28,recessive,childhood to adult,"Adrenoleukodystrophy, Adult Adrenoleukodystrophy"
ABHD12,20p11.21,recessive,childhood to late teens,"Polyneuropathy with Hearing Loss, Ataxia, Retinitis Pigmentosa, and Cataract"
ACBD5,10p12.1,recessive,childhood,Retinal Dystrophy and White Matter Disease
ACO2,22q13.2,recessive,infancy,Infantile Cerebellar-Retinal Degeneration; Optic Atrophy 9
ACOX2,3p14.3,recessive,congenital,Bile Acid Synthesis Defect 6
ACP33,15q22.31,recessive,2nd to 6th decade,SPG21; Spastic Paraplegia with Dementia and Extrapyramidal Signs
ADAM22,7q21.12,recessive,infancy,EIEE61
ADCK3,1q42.13,recessive,1.5-11 years,"SCAR9; ARCA2; Cerebellar ataxia, seizures and ubiquinone deficiency"
ADD3,10q25.1,recessive,early childhood,CPSQ
ADSL,22q13.1,recessive,childhood,Adenylosuccinase Deficiency
AFG3L2,18p11.21,dominant,12 to 36 years (mean 19),SCA28
AHI1,6q23.3,recessive,congenital,JBTS3
AIFM1,Xq26.1,recessive,infancy,Combined Oxidative Phosphorylation Deficiency 6; Cowchock Syndrome; Cerebellar Ataxia
AIMP1,4q24,recessive,infancy,HLD3
AIRE,21q22.3,dominant and recessive,first decade,Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED)
ALDH18A1,10q24.1,dominant and recessive,infancy to 4th decade,SPG9A; Gastroesophageal Refulx and Spastic Paraparesis with Amyotrophy; SPG9B
ALDH3A2,17p11.2,recessive,<2 years,Sjogren-Larsson Syndrome
ALDH5A1,6p22.3,recessive,childhood to early adult,Succinate Semialdehyde Dehydrogenase Deficiency
ALDP,Xq28,recessive,2nd to 4th decade,Adrenomyeloneuropathy
ALG13,Xq23,dominant,infancy,EIEE36; Congenital Disorder of Glycosylation Is
ALG6,1p31.3,recessive,<1 year,Carbohydrate deficient glycoprotein syndrome type 1C (CDG1C)
ALS2,2q33.1,recessive,infancy,Infantile SPGl; Juvenile ALS2; Juvenile PLS
ALS4,9q33,dominant,36 to 55 years,SPG19
ALS5,15q21.1,recessive,1 to 50 years,SPG11
AMACR,5p13.2,recessive,congenital; adult,Congenital Bile Acid Synthesis Defect 4; Alpha-Methylacyl-CoA Racemase Deficiency
AMPD2,1p13,recessive,1 to 2 years,SPG63
ANO3,11p14.3-2,dominant,19 to 40 years (mean 29),Dystonia 24
ANO10,3p22.1,recessive,13-45 years,SCAR10; Ataxia with Motor Neuropathy 2
AP1S2,Xp22.2,recessive,congenital to infancy,Syndromic Mental Retardation 5; Pettigrew Syndrome
AP3B2,15q25.2,recessive,infancy,EIEE48
AP4B1,1p13.2,recessive,congenital,CPSQ5
AP4E1,15q21.2,recessive,infancy,CPSQ4; SPG51
AP4M1,7q22.1,recessive,congential,CPSQ3; SPG50
AP4S1,14q12,recessive,congenital,CPSQ6; SPG52
AP5Z1,7p22.1,recessive,13 to 60 years,SPG48
APOB,2p21.4,dominant and recessive,teens to adult,dominant Hypercholestrolema; recessive Hypobetalipoprotenemia
APOE,19q13.32,dominant,adult,Lipoprotein Glomerulopathy; Hyperlipoproteinemia III; Alzheimer Disease 2
APOPT1,14q32.33,recessive,infancy to early childhood,Mt Complex IV Deficiency
APOPT1 ,14q32.33,dominant,congential,Mitochondrial complex IV deficiency 
APP,21q21.3,dominant,44 to 58 years,Cerebral amyloid angiopathy
APTX,9p21.1,recessive,1-16 years (mean 4.7),Ataxia with Oculomotor Apraxia 1 (AOA1); Cerebellar Ataxia with Muscle CoQ10 Deficiency
ARG1,6q23.2,recessive,congenital,Argininemia
ARL13B,3q11.1,recessive,congenital,JBTS8
ARL6IP1,16p12.3,recessive,1-2 years,SPG61
ARMC9,2q37.1,recessive,congenital,JBTS30
ARSA,22q13.33,recessive,infancy,Metachromatic Leukodystrophy
ARSI,5q32,recessive,1.5 years,SPG66
ARV1,1q42.2,recessive,infancy,EIEE38
ARX,Xp21.3,recessive,congenital,"EIEE1; Infantile Spasms, Mental Retardation, and Spacticity"
ASL,7q11.21,recessive,infancy,Argininosuccinic Aciduria
ASS1,9q34.11,recessive,congenital to young adult,Citrullinemia
ATCAY,19p13.3,recessive,early childhood,Cayman Ataxia
ATG5,6q21,recessive,congenital,SCAR25; Spinocerebellar Ataxia
ATL1,14q22.1,dominant,childhood to 30's,SPG3A
ATM,11q22.3,recessive,1-2 years,Ataxia Telangectasia
ATN1,12p13.31,dominant,1 to 76 years (mean 31),DRPLA ; Dentatorubral-Pallidoluysian
ATP13A2,1p36.13,recessive,juvenile to adult,SPG78; Spastic Ataxia; Kufor-Rakeb Syndrome
ATP1A2,1q23.2,dominant,childhood,Alternating Hemiplegia of Childhood 1
ATP1A3,19q13.2,dominant,1 to 5 years,"CAPOS Syndrome, Adult Rarid-onset Ataxia; Dystonia 12"
ATP2B2,3p25.3,dominant,childhood,Ataxia without Deafness
ATP2B3,Xq28,recessive,congenital,SPAX1; X-linked Spinocerebellar Ataxia 1
ATP5A1,18q21.1,recessive,infancy,Mt Complex Deficiency Type 4
ATP5E,20q13,recessive,congenital,Mt Complex V Deficiency
ATP6,Mt,maternal,childhood,Mt Complex V Deficiency with Ataxia and Encephalomyopathy
ATP6AP2,Xp11.4,recessive,14 to 58 years,X-linked Parkinsonism with Spacticity
ATP7B,13q14.3,recessive,juvenile and late onset forms,Wilson's Disease
ATP8A2,13q12.13,recessive,childhood to early adult,Cerebellar Ataxia with ID and Dysequilibrium Syndrome 4
ATPAF2,17p11.2,recessive,congenital,Mt Complex V
ATR,3q23,dominant or recessive,infancy,"?Cutaneous telangiectasia and cancer syndrome, familial; Seckel Syndrome 1"
ATRX,Xq21.1,recessive,congenital,Spastic Diplegia with Mental Retardation and Small Testes
ATXN1,6p22.3,dominant,4 to 74 years (mean 40's),SCA1
ATXN10,22q13.31,dominant,10 to 40 years,SCA10
ATXN2,12q24.12,dominant,childhood to adult,SCA2
ATXN3,14p32.12,dominant,childhood to adult,SCA3; Machado-Joseph
ATXN7,3p14.1,dominant,1 to 77 years (mean 20's),SCA7
ATXN8,13q21.33,dominant,mean 40 to 50 years,SCA8
AUH,9q22.31,recessive,infancy,3-methylglutaconic Aciduria Type I
B4GALNT1,12q13.3,recessive,2 to 19 years,SPG26
B9D1,17p11.2,recessive,congenital,JBTS27; Meckel Syndrome 9
B9D2,19q13.2,recessive,congenital,JBTS34; Meckel Syndrome 10
BCKDHB,6q14.1,recessive,childhood to young adult,Maple Syrup Urine Disease Ib
BCS1L,2q35,recessive,congenital to infancy,Mt Complex III Deficiency 1; Leigh Syndrome; Bjornstad Syndrome
BEAN,16q21,dominant,45 to 72 years,SCA31
BRAT1,7p22.3,recessive,congenital,Rigidity and Multifocal Seizure Syndrome
BSCL2,11q12.3,dominant,2 to 40 years,SPG17; Silver Syndrome; Spastic Paraplegia with Amyotrophy of Hands and Feet
BSN,3p21.31,dominant,adult,Supranuclear Palsy-like Syndrome
BTD,3q25.1,recessive,congenital,Biotinidase deficiency
C12orf65,12q24.31,recessive,childhood,SPG55; Combined Oxidative Phosphorylation Deficiency 7
C19orf12,19q.12,recessive,7 to 12 years,SPG43
C5orf42,5p13.2,recessive,congenital,JBTS17; Orofaciodigital Syndrome VI
C9ORF72,9p21.2,dominant,adult,Frontotemporal Dementia and/or ALS1; Progressive SCA with Psychiatric Disorders
CA8,8q12.1,recessive,childhood,Cerebellar Ataxia and Mental Retardation with or without Quadrupedal Locomotion 3
CACNA1A,19p13.2,dominant,<20 years,SCA6; Spinocerebellar Ataxia 6; Episodic Ataxia 2 (EA2); EIEE42
CACNA1G,17q21.33,dominant,9 to 78 years,SCA42
CACNB4,2q23.3,dominant,30s to 40's,Episodic Ataxia 5 (EA5); Susceptibility to Epilepsy
CAMTA1,1p36.31,dominant,infancy to childhood,Cerebellar Ataxia with Mental Retardation
CAPN1,11q13.1,recessive,19 to 36 years,SPG76; Spastic Paraplegia; Spacticity with Ataxia
CASK,Xp11.4,dominant,congenital,Mental Retardation with or without Nystagmus; Mental Retardation and Microcephaly with Pontine and Cerebellar Hypoplasia; FG Syndrome 4 
CAV1,7q31.2,dominant,adult,"Partial Lipodystrophy, Congenital Cataracts, and Neurodegeneration syndrome"
CC2D2A,4p15.32,recessive,congenital,JBTS9; Meckel Syndrome 6; COACH Syndrome
CCDC88C,14q32.11,dominant,5th decade,SCA40
CCT5,5p15.2,recessive,childhood,Hereditary Sensory Neuropathy with Spastic Paraparesis
CDKL5,Xp22.13,dominant,infancy,EIEE2
CECR1,22q11.1,recessive,childhood,"Polyarteritis nodosa, childhood-onset"
CEP104,1p36.3,recessive,congenital,JBTS25
CEP120,5q23.2,recessive,congenital,JBTS31; Short-rib Thoracic Dysplasia 13 with or without Polydactyly
CEP290,12q21.32,recessive,congenital,JBTS5; Bardet-Biedl Syndrome 14; Meckel Syndrome 4; Senior-Loken Syndrome 6; Leber Congenital Amaurosis 10
CEP41,7q32.2,recessive,congenital,JBTS15
CHAMP1,13q34,dominant,infancy,Mental Retardation 40
CHCHD10,22q11.23,dominant,adult,Frontotemporal Dementia and/or ALS 2; Isolated Mt Myopathy; Spinal Muscular Dystrophy
CHMP1A,16q24.3,recessive,congenital,Pontocerebellar Hyploplasia8
CHP1,15q15.1,recessive,1-5 years,Spastic Ataxia with Motor Neuropathy
CIZ1,9q34.11,dominant,40s to 50's,Dystonia 23
CLCN2,3q27.1,dominant and recessive,childhood or adult,dominant Susceptibility to Juvenile Myoclonic Epilepsy 8; dominant Susceptibility to Juvenile Absence Epilepsy 3; dominant Susceptibility to Idiopathic Generalized Epilepsy 11; recessive Leukoencephalopathy with Ataxia (LKPAT)
CLN3,16p12.1,recessive,childhood,Neuronal Ceroid Lipofuscinosis 3
CLN5,13q22.3,recessive,infancy to childhood,Neuronal Ceroid Lipofuscinosis 5
CLN6,15q21.1,recessive,childhood to adult,Neuronal Ceroid Lipofuscinosis 6; Adult-onset Kufs Type CLN6
CLN8,8p23.3,recessive,childhood,Neuronal Ceroid Lipofuscinosis 8; CLN8 with Epilepsy
CLP1,11q12.1,recessive,infancy,Pontocerebellar Hypoplasia10
CLPB,11q13.4,recessive,congenital,"3-methylglutaconic Aciduria Type VII with Cataracts, Neurologic Involvement and Neutropenia"
CLPP,19p13.3,recessive,congenital,Perrault Syndrome 3
CNPY3,6p21.1,recessive,infancy,EIEE60
CNTN1,12q12,recessive,congenital,Congenital Myopathy (Compton-North)
COA5,2q11.2,recessive,congenital,Mitochondrial Complex IV Deficiency
COA7,1p32.3,recessive,infancy,Mt Complex IV Deficiency; Ataxia with Neuropathy
COG4,16q22.1,recessive,congenital,Congenital Disorder of Glycosylation Type Iij
COL18A1,21q22,recessive,congenital,Ataxia with Epilepsy and Eye Disorders; Knobloch Syndrome Type 1
COL6A3,2q37.3,dominant and recessive,congenital to adult,dominant and recessive Bethlem Myopathy 1 and Ullrich Muscular Dystrophy 1; dominant Dystonia 27
COQ2,4q21.22,dominant or recessive,adult; teens to early adult,dominant or recessive Multi-system Atrophy; recessive Coenzyme Q10 Deficiency Primary 1
COQ4,9q34.11,recessive,congenital,Coenzyme Q10 Deficiency Primary 7
COQ5,12q24.31,recessive,early childhood,Cerebellar Ataxia with Encephalomyopathy
COQ6,14q24.3,recessive,1 to 2 years,"Coenzyme Q10 deficiency, primary, 6"
COQ8A,1q42.13,recessive,1.5-11 years,"SCAR9; ARCA2; Cerebellar ataxia, seizures and ubiquinone deficiency"
COQ9,16q21,recessive,congenital,"Coenzyme Q10 deficiency, primary, 5"
CO2,Mt,maternal,childhood to early adult,Cytochrome c oxidase deficiency
COX10,17p12,recessive,infancy,Leigh Syndrome due to Mt COX4 Deficiency
COX10 ,17p12,dominant,infancy to early childhood,Mitochondrial complex IV deficiency; Leigh Syndrome due to COX4 Deficiency
COX14,12q13.12,recessive,congenital,Mitochondrial complex IV deficiency
COX15,10q24.2,recessive,infancy to early childhood,"Cardiomyopathy, hypertrophic, early-onset fatal; Leigh syndromedue to cytochrome c oxidase deficiency"
COX20 ,1q44,dominant,infancy to adulthood,Mitochondrial complex IV deficiency 
COX6B1,19q13.12,recessive,infancy,Cytochrome c oxidase deficiency
CP,3q24-25,recessive,40s to 50's,Cerebellar Ataxia; Systemic Hemosiderosis; Hereditary Hypoceruloplasminemia
CPLX1,4p16.3,recessive,infancy,Myoclonic epilepsy with ID
CPS1,2q34,recessive,congenital to young adult,Carbamoylphosphate Synthetase Deficiency
CPT1C,19q13.33,dominant,19 to 48 years,SPG73
CREBBP,16p13.3,dominant,infancy,Rubenstein-Taybi Syndrome
CSPP1,8q13.2,recessive,congenital,Joubert Syndrome type 21
CSTB,21q22.3,recessive,6-20 (mean 13),Progressive Myoclonic Epilepsy type 1A (EPM1A); Unverricht-Lundborg syndrome
CTBP1,14p16.3,dominant,8 ro 20 years,"Intellectual disability, failure to thrive, hypotonia, ataxia, and tooth enamel defects"
CTC1,17p13.1,recessive,childhood,Cerebroretinal microangiopathy with calcifications and cysts
CTDP1,18q23,recessive,4 to 32 years,"Congenital cataracts, facial dysmorphism, and neuropathy"
CTSA,20q13.12,recessive,teens to early adult,Galactosialidosis
CTSD,11p15.5,recessive,8 to 15 years,Neuronal Ceroid Lipofuscinosis 10
CTSF,11q13.2,recessive,20's ,Kufs Type Neuronal Ceroid Lipofuscinosis 13
CUL4B,Xq24,recessive,early childhood,"Mental retardation, X-linked, syndromic 15 (Cabezas type)"
CWF19L1,10q24.31,recessive,congenital,SCAR17; Congenital Ataxia with Mental Retardation
CYP27A1,2q35,recessive,early teens,Cerebrotendinous xanthomatosis
CYP2U1,4q25,recessive,birth to 8 years,SPG56; Spastic Paraplegia with Thin Corpus Callosum
CYP7B1,8q12.3,recessive,infancy,SPG5A
DARS2,1q25.1,recessive,3 to 15 years,Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation
DBT,1p21.2,recessive,infancy,"Maple syrup urine disease, type II"
DCAF8,1q23.2,dominant,childhood to adult,Giant Axonal Neuropathy 2
DCTN1,2p13.1,dominant or recessive,adult,dominant Distal hereditary Motor Neuropathy type VIIB; dominant Perry Syndrome; dominant and recessive susceptibility ot ALS
DCX,Xq23,recessive,childhood to early adult,"Subcortical laminal heteropia, X-linked; Lissencephaly, X-linked"
DDHD1,14q22.1,recessive,infancy to 15 years,SPG28
DDHD2,8p11.23,recessive,<2 years,SPG54; Spastic Paraplegia with Thin Corpus Callosum
DENND5A,11p15.4,recessive,infancy,EIEE49
DGAT2,11q13.5,dominant,childhood,Early-onset CMTD
DKC1,Xq28,recessive,congenital to adult,"Dyskeratosis congenita, X-linked; Hoyeraal-Hreidarsson syndrome"
DLAT,11q23.1,recessive,infancy,Pyruvate dehydrogenase E2 deficiency
DLD,7q31.1,recessive,infancy,"Maple syrup urine disease, type III; Leigh syndrome"
DMXL2,15q21.2,dominant or recessive,childhood to late teens; childhood,dominant Deafness 71; recessive Polyendocrine-polyneuropathy syndrome
DNAJC19,3q26.33,recessive,<3 years,Dilated Cardiomyopathy with Ataxia (DCMA); 3-Methyglutaconic Aciduria type V
DNAJC3,13q32.1,recessive,childhood to early teens,"Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus "
DNAJC5,20q13,dominant,adult,Parry Type Neuronal Ceroid Lipofuscinosis 4
DNM1,9q34.11,dominant,dominant,EIEE31
DNM1L,12p11.21,dominant and recessive,infancy to childhood,dominant and recessive Lethal Encephalopathy Due to Mt Peroxisomal Fission 1; dominant Optic Atrophy 5
DNM2,19p13.2,dominant,congenital to 40's,CMTD2M; CMTDIB; Centronuclear Myopathy1
DNMT1,19p13.2,dominant,childhood to 5th decade,Cerebellar Ataxia with Deafness and Narcolepsy; Hereditary Sensory Neuropathy IE
DOCK3,3p21.2,recessive,childhood,"DD, Ataxia and Hypotonia"
DOCK7,1p31.3,recessive,infancy,EIEE23
DPM1,20q13.13,recessive,infancy to early childhood,"Congenital disorder of glycosylation, type Ie"
DRD3,3q13.31,dominant,16-47 years,Familial Essential Tremor 1
DRP2,Xq22.1,recessive,18 to 50 years,CMTDXI
DSTYK,1q32.1,recessive,early childhood,SPG23; Spastic Paraplegia with Pigmentary Abnormalities
DYNC1H1,14q32.31,dominant,childhood,"CMTD20; Lower Extremity Spinal Muscular Dystrophy; Mental retardation, autosomal dominant 13"
DYRK1A,21q22.13,dominant,congenital,Mental Retardation 7
EBF3,10q26.3,dominant,2 to 25 years,Hypotonia Ataxia and DD (HADDS)
EEF1A2,20q13.33,dominant,infancy,EIEE33
EEF2,19p13.3,dominant,26-60 years,SCA26
EGR2,10q21.3,dominant and recessive,congenital to early adult,dominant CMTD1D; dominant and recessive Dejerine-Sottas Disease; dominant and recessive Congenital Hypomyelinating Neuropathy 1
EIF2B1,12q24.31,recessive,childhood,Leukoencephalopathy with Vanishing White Matter
EIF2B2,14q24.3,recessive,childhood,Leukoencephalopathy with Vanishing White Matter
EIF2B3,1p34.1,recessive,childhood,Leukoencephalopathy with Vanishing White Matter; Childhood Ataxia with CNS Hypomyelination
EIF2B4,2p23.3,recessive,childhood,Leukoencephalopathy with Vanishing White Matter
EIF2B5,3q27.1,recessive,childhood,Leukoencephalopathy with Vanishing White Matter
EIF4G1,3q27.1,dominant or recessive,adult; congenital,dominant Parkinson Disease 18; recessive Rett-like Syndrome
ELF2,4q31.1,dominant,adult,Cerebellar Ataxia with Neuropathy and Bilateral Vestibular Areflexia Syndrome (CANVAS)
ELOVL4,6q14.1,dominant,infancy,SCA34
ELOVL5,6p12.1,dominant,4th to 6th decade,SCA38
EMC1,1p36.13,recessive,early childhood,Cerebellar Atrophy with Visual Impairment and Psychomotor Retardation 
ENTPD1,10q24.1,recessive,1 to 4 years,SPG64
EOMES,3p24.1,recessive,congenital,Microcephaly with polymicrogyria
EP300,15q21.1,dominant,20 years,Spinocerebellar Ataxia
EPM2A,6q24.3,recessive,8 to 18 years,Progressive Myoclonic Epilepsy 2A
EPRS,1q41,recessive,infanct to young adult,HLD15
EPT1,2p23.3,recessive,infancy to early childhood,Complicated Spastic Paraplegia
ERCC1,19q13.32,recessive,congenital,Cockayne Syndrome; Cerebrooculofacioskeletal Syndrome 4
ERCC2,19q13.32,recessive,infancy to early childhood,Xeroderma pigmentosum GroupD;  Photosensitive Trichothiodystrophy 1; Cerebrooculofacioskeletalsyndrome 2
ERCC3,2q14.3,recessive,childhood to adult,Xeroderma pigmentosum GroupB;  Photosensitive Trichothiodystrophy 2
ERCC4,16p13.12,recessive,40s,Xeroderma pigmentosum GroupF with Cerebellar Ataxia and Chorea
ERCC5,13q33.1,recessive,childhood to young adult,Xeroderma pigmentosum Group G; Cerebrooculofacioskeletalsyndrome 3
ERCC6,10q11.23,recessive,congenital,Cockayne Syndrome B; UV-sensitive Syndrome 1; Cerebrooculofacioskeletal Syndrome 1; De Sanctis-Cacchione Syndrome
ERCC8,5q12.1,recessive,childhood,Cockayne Syndrome A; UV-sensitive Syndrome 2
ERLIN1,10q24.31,recessive,1.5 to 13 years,SPG62
ERLIN2,8p11.23,recessive,2 to 6 years,SPG18
ETHE1,19q13.31,recessive,infancy to early childhood,Ethylmalonic encephalopathy
EXOSC3,9p13.2,recessive,congenital,Pontocerebellar hypoplasia type 1B 
FA2H,16q23.1,recessive,4 to 11 years,SPG35; Spastic Paraplegia with Leukodystrophy and Dystonia
FAM126A,7p15.3,recessive,infancy,HLD5
FAM36A,1q44,recessive,1-3 years,Ataxia-Pyramidal Syndrome; Mitochondrial Complex IV Deficiency
FARS2,6p25.1,recessive,childhood,SPG77; Combinaed Oxidative Phosphorylation Deficiency 14
FASTKD2,2q33.3,recessive,infancy to adulthood,Mitochondrial complex IV deficiency
FAT1,4q35.2,dominant,60 to 70 years,Spinocerebellar Ataxia
FAT2,5q33.1,dominant,50 to 60 years,SCA45
FBXL4,6q16.1-2,recessive,infancy,Mt DNA Depletion Syndrome 13
FGF12,3q28-29,dominant,infancy,EIEE47
FGF14,13q33.1,dominant,childhood,SCA27
FKRP,19q13.32,recessive,congenital; congenital; adult,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eyeanomalies), type A, 5; Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5"
FKTN,9q31.2,recessive,congenital; congenital; adult,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eyeanomalies), type A, 4; Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4; Cardiomyopathy,dilated, 1X; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4"
FLNC,7q32.1,dominant,adult,Distal Myopathy 4; Myofibrillar Myopathy 5
FLRT1,11q13.1,recessive,2 to 3 years,SPG68
FLVCR1,1q32.3,recessive,early childhood,Posterior Column Ataxia with Retinitis Pigmentosa
FMR1,Xq27.3,dominant,>50 years,Fragile X Syndrome; Fragile X with Ataxia Syndrome
FOLR1,11q13.4,recessive,childhood,Neurodegeneration due to cerebral folate transport deficiency
FOXG1,14q12,dominant,childhood to early adult,"Rett syndrome, congenital variant"
FOXRED1,11q24.2,recessive,infancy,Mitochondrial Complex I Deficiency
FRMD4A,10p13,recessive,congenital,Agenesis Corpus Callosum with Facial Anomolies and Cerebellar Ataxia
FRRS1L,9q31.3,recessive,infancy,EIEE37
FTL,19q13.33,dominant,adult,Hyperferritinemia-cataract syndrome; Neurodegenerationwith brain iron accumulation 3
FUS,16p11.2,dominant,early adult,Essential Tremor 4; ALS with or without Frontotemporal Dementia
FXN,9q21.11,recessive,teens,Friedreich Ataxia
GABBR2,9q22.33,dominant,infancy,EIEE59
GABRA1,5q34,dominant,infancy,EIEE19
GABRB1,4p12,dominant,infancy,EIEE45
GABRB3,15q12,dominant,infancy,EIEE43
GAD1,2q31.1,recessive,childhood,Cerebral Palsy Spastic Quadriplegic (CPSQ1)
GALC,14q31.3,recessive,infancy; adult,Krabbe disease; Adult-onset Krabbe with Cerebellar Ataxia
GAMT,19p13.3,recessive,early childhood,Cerebral creatine deficiency syndrome 2
GAN,16q23.2,recessive,childhood,Giant Axonal Neuropathy 1
GARS,7p14.3,dominant,early to late adult,CMTD2D; Distal Hereditary Motor Neuropathy VA
GBA,1q22,dominant or recessive,infancy; adult,"recessive Gaucher disease, type II and Gaucher disease, type III; dominant {Lewy body dementia, susceptibility to}"
GBA2,9p13.3,recessive,3 to 15 years,SPG46; Spastic Ataxia
GBE1,3p12.2,recessive,congenital,"Glycogen storage disease IV; Polyglucosan body disease, adult form"
GCH1,14q22.2,dominant or recessive,childhood to early adult; infancy to early childhood,"dominant Dystonia,DOPA-responsive with or without hyperphenylalaninemia; recessive Hyperphenylalaninemia, BH4-deficient, B"
GCLC,6p12.1,recessive,childhood; adult,"Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency; {Myocardial infarction, susceptibility to}"
GDAP1,8q21.11,dominant and recessive,mostly childhood but to 50's for dominant CMTD2K,dominant and recessive CMTD2K; recessive CMTDIA; recessive CMTD4A; recessive Axonal CMTD with Vocal Cord Paresis
GFAP,17q21.31,dominant,12 to 71 years,Branchial Myoclonus with Spastic Paraparesis and Cerebellar Ataxia; Alexander Disease
GJA1,6q22.31,dominant or recessive,congenital to early childhood,dominant or recessive Oculodentodigital dysplasia; recessive Craniometaphyseal dysplasia; dominant Syndactyly III
GJB1,Xq13.1,dominant,childhood,CMTDX1
GJC2,1q42.13,recessive,infancy,HLD2
GLB1,3p22.3,recessive,infancy,"GM-1 Gangliosidosis Types I,II,III; Mucopolysaccharidosis Type IVB"
GM2A,5q33.1,recessive,infancy,GM2-Gangliosidosis
GMPPA,2q35,recessive,congenital,Achalasia-Alacrimia-Intellectual Dysfunction
GMPPB,3p21.31,recessive,congenital," (congenital with brain and eye anomalies), type A, 14 and type B, 14; Muscular dystrophy-dystroglycanopathy (limb girdle), type C 14"
GNAL,18p11.21,dominant,7 to 50 years (mean 28),Dystonia 25
GNAO1,16q13,dominant,infancy,EIEE17
GNB4,3q26.33,dominant,5 to 70 years,CMTDIF
GON7,14q32.12,recessive,4 years,Galloway-Mowat Syndrome 5 (GAMOS5)
GOSR2,17q21.32,recessive,1-3 years,Ataxia with Progressive Myoclonus Epilepsy; Progressive Myoclonic Epilepsy type 6 (EPM6)
GPAA1,8q24.3,recessive,3 to 38 years,Glycosylphosphatidylinositol biosynthesis defect 15
GPI,19q13.11,recessive,childhood,"Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency"
GPR56,16q21,recessive,childhood to teens,"Polymicrogyria, bilateral frontoparietal"
GRIA4,11q22.3,dominant,congenital,Neurodevelopmental Disorder with or without Seizures and Gait Abnormalities
GRID2,4q22.1-2,recessive,early infancy,Ataxia with Oculomotor Apraxia and Cerebellar Atrophy (SCAR18)
GRIK2,6q16.3,recessive,infancy,"Mental Retardation 6; DD with Seizures; Dystonia, Tremors and Myoclonus"
GRIN1,9q34.3,dominant,chlidhood to early teens,Neurodevelopmental Disorder with or without Hyperkinetic Movements and Seizures
GRIN2B,12p13.1,dominant,infancy,EIEE27
GRIN2D,19q13.33,dominant,infancy,EIEE46
GRM1,6q24.3,dominant and recessive,congenital,SCA44 and SCAR13; Congenital Cerebellar Ataxia
GRN,17q21.31,dominant,adult (mean 51),Frontotemporal Lobar Degeneration with Ubiquitin-positive Inclusions; Neuronal Ceroid Lipofuscinosis 11
GSS,20q11.22,recessive,childhood to teens,Glutathione synthetase deficiency
GUF1,4p12,recessive,iinfancy,EIEE40
HACE1,6q16.3,recessive,congenital,SPG; Spastic Paraplegia and Psychomotor Retardation with or without Seizures
HARS,5q31.3,dominant or recessive,childhood to adult; childhood,dominant CMTD2W; recessive Usher syndrome type 3B
HCN1,5p12,dominant,infancy,EIEE24
HEPACAM,11q24.2,dominant or recessive,childhood,"dominant Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation; recessive Megalencephalic leukoencephalopathy with subcortical cysts 2A"
HERC1,15q22.31,recessive,infancy to childhood,"Macrocephaly, dysmorphic facies, and psychomotor retardation"
HEXA,15q23,recessive,infancy,"Tay-Sachs disease; GM2-gangliosidosis, several forms; [Hex A pseudodeficiency]"
HEXB,5q13.3,recessive,infancy,"Sandhoff disease, infantile, juvenile, and adult forms"
HIBCH,2q32.2,recessive,infancy,3-hydroxyisobutryl-CoA hydrolase deficiency; Dystonia and Ataxia
HIKESHI,11q14.2,recessive,infancy,HLD13
HINT1,5q31.1,recessive,3 to 28 years,Neuromyotonia and Axonal Neuropathy
HLCS,21q22.13,recessive,infancy,Holocarboxylase synthetase deficiency
HNRNPH2,Xq22.1,dominant,2 to 34 years,"Mental retardation, X-linked, syndromic, Bain type"
HNRNPU,1q44,dominant,infancy,EIEE54
HPCA,1p35.1,recessive,childhood,Torsion Dystonia 2
HPRT1,Xq26.2-3,recessive,early childhood,Lesch-Nyhan Syndrome
HSD17B4,5q23.1,recessive,2 to 10 years,Ataxia with Hypogonadism and Polyneuropathy
HSPD1,2q33.1,dominant,17 to 68 years,SPG13; HLD4
HTRA1,10q26.13,dominant or recessive,60's; ealry adult,"dominant Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2; recessive CARASIL syndrome"
IBA57,1q42.13,recessive,childhood; infancy,Spastic paraplegia 74; Multiple Mt Dysfunctions Syndrome 3
IFRD1,7q31.1,dominant,13 to 27 years,Hereditary Sensory-Motor Neuropathy with Ataxia (SMNA)
IFT140,16p13.3,recessive,childhood to 30's,Retinitis Pigmentosa 80; Mainzer-Saldino syndrome
IKBKAP,9q31.3,recessive,childhood,Familial Disautonomia; Hereditary Sensory and Autonomic Neuropathy
INF2,14q32.33,dominant,5 to 28 years,CMTDIE
INPP5E,9q34,recessive,congenital,JBTS1
ISPD,7p21.2-1,recessive,congenital; childhood,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eyeanomalies), type A, 7; Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7"
ITM2B,13q14.2,dominant,40 to 60 years,Retinal Dystrophy and Ganglion Cell Abnormalities; Familial Dementia with Amyloid Angiopathy and Spastic Ataxia
ITPA,20p13,recessive,infancy,EIEE35
ITPR1,3p26.1,dominant,10 to 66 years,"SCA15, SCA16, and SCA29"
KANK1,9p24.3,recessive,congenital,CPSQ2
KARS,16q23.1,recessive,childhood,CMTDIB; Deafness 89
KAT6A,8p11.21,dominant,childhood,Mental Retardation 32
KCNA1,12p13.32,dominant,childhood to 2nd decade,Episodic Ataxia 1 (EA1); Myokymia Syndrome
KCNA2,1p13.3,dominant,childhood,EIEE32; EA
KCNB1,20q13.13,dominant,infancy,EIEE26
KCNC1,11p15.1,dominant,3 to 15 years (median 9.5),Progressive Myoclonic Epilepsy (EPM7); MEAK
KCNC3,19q13.33,dominant,early childhood,SCA13
KCND3,1p13.2,dominant,20 to 55 years,SCA19 and SCA22
KCNJ10,1q23.2,recessive,<5 years,SESAME Syndrome
KCNMA1,10q22.3,dominant and recessive,infancy,dominant Paroxysmal Nonkinesigenic Dyskinesia 3 with or without Epilepsy; recessive Cerebellar Atrophy with DD and Seizures
KCNQ2,20q13.33,dominant,infancy,EIEE7
KCNT1,9q34.3,dominant,infancy,EIEE14
KCNT2,1q31.3,dominant,infancy,EIEE57
KCTD7,7q11.21,recessive,5 months,Progressive Myoclonic Epilepsy type 3; Opsoclonus-Myoclonus-Ataxia; Neuronal Ceroid Lipofuscinosis 14
KCTD17,22q12.3,dominant,5 ot 20 years,Myoclonic Dystonia 26
KIAA0196,8q24.13,dominant,22 to 60 years,SPG8
KIAA0556,16p12.1,recessive,congenital,JBTS26
KIAA0586,14q23.1,recessive,congenital,JBTS23; Short-rib Thoracic Dysplasia 14 with Polydactyly
KIDINS220,2p25.1,dominant,congenital,"Spastic Paraplegia, ID, Nystagmus, and Obesity"
KIF1A,2q37.3,dominant and recessive,early childhood,dominant Mental Retardation 9; recessive Hereditary Sensory IIC; dominant and recessive SPG30
KIF1B,1p36.22,dominant,childhood,"Charcot-Marie-Tooth disease, type 2A1; Pheochromocytoma; {Neuroblastoma, susceptibility to, 1}, IC"
KIF1C,17p13.2,recessive,childhood to early teens,"Spastic ataxia 2, autosomal recessive "
KIF26B,1q44,dominant,74 to 90 years,Spinocerebellar Ataxia
KIF5A,12q13.3,dominant,10 to 23 years,SPG10
KIF7,15q26.1,recessive,congenital,JBTS12; Acrocallosal Syndrome; Hydrolethalis Syndrome 2; Al-Gazali-Bakalinova Syndrome
KLC2,11q13.2,recessive,infancy,"Spastic Paraparesis, Optic Atrophy, and Polyneuropathy"
KMT2B,19q13.12,dominant,childhood,Childhood Dystonia 28
KPNA7,7q22.1,recessive,infancy,EIEE unknown significance
KY,3q22.2,recessive,childhood,"Myopathy, myofibrillar, 7"
L1CAM,Xq28,recessive,congenital,SPG1
L2HGDH,14q22.1,recessive,infancy,L-2 Hydroxyglutaric Aciduria
LAGE3,Xq28,recessive,1-2 years,Galloway-Mowat Syndrome 2 (GAMOS2)
LAMA1,18p11.31,recessive,congenital,Cerebellar Dysplasia with Cysts; Poretti-Boltshauser syndrome
LAMB1,7q31.1,recessive,congenital,Lissencephaly 5
LARGE1,22q12.3,recessive,congenital,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eyeanomalies), type A; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6"
LARS2,3p21.31,recessive,childhood to young adult,"Perrault Syndrome; Hydrops, Lactic Acidosis, and Sideroblastic Anemia"
LIG4,13q33.3,recessive,infancy,"LIG4 syndrome; {Multiple myeloma, resistance to}; Severe combined immunodeficiency with sensitivity to ionizing radiation"
LITAF,16p13.13,dominant,early to late adult,CMTD1C
LMNA,1q22,dominant and recessive,congenital to early adult,dominant and recessive Emery-Dreifuss Muscular Dystrophy 2 and 3; dominant CMTD2B1; dominant Limb-Girdle Muscular Dystrophy 1B; dominant Familial Partial Lipodystrophy
LMNB1,5q23.2,dominant,adult,Adult-onset Leukodystrophy
LMNB2,19p13.3,dominant or recessive,childhood to late teens; childhood,"dominant Susceptibility to partial acquired Lipodystrophy; recessive Epilepsy, progressive myoclonic, 9; "
LRP4,11p11.2,dominant or recessive,teens to adult; congenital; congenital,dominant or recessive Sclerosteosis 2; recessive Congenital Myasthenic Syndrome 17; recessive Cenani-Lenz Syndactyly Syndrome
LRPPRC,2p21,recessive,infancy,"Leigh syndrome, French-Canadian type"
LRSAM1,9q33.3,dominant and recessive,9 to 76 years,dominant and recessive CMTD2P
LYST,1q42.3,recessive,adult,recessive Chediak-Higashi syndrome; CHS with spastic paraplegia with cerebellar ataxia and neuropathy
MAG,19q13.12,recessive,infancy,SPG75; Spastic Ataxia 75
MAN2B1,19p13.13,recessive,childhood,"Mannosidosis, alpha-, types I and II"
MAPK10,4q21.3,recessive,congenital,"Epileptic encephalopathy, Lennox-Gastaut type"
MARS2,2q33.1,recessive,childhood to 59 (mean 8),Spastic Ataxia 3 with Leukoencephalopathy; Combined Oxidative Phosphorylation Deficiency 25
MBD5,2q23.1,dominant,congenital,"Mental retardation, autosomal dominant 1"
MCM3AP,21q22.3,recessive,early childhood,CMTD with ID
MCSZ,19q13.33,recessive,infancy,"Microcephaly, Seizures and DD"
MECP2,Xq28,dominant,1 to 2 years,Rett Syndrome
MECR,1p35.3,recessive,childhood,"Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities"
MED13L,12q24.21,dominant,childhood,Mental Retardation and Distinctive Facial Features with or without Cardiac Defects
MED25,19q13.33,recessive,28 to 42 years,CMTD2B2; Basel-Vanagait-Smirin-Yosef Syndrome
MFSD8,4q28.2,recessive,infancy to childhood,Neuronal Ceroid Lipofuscinosis 7
MGME1,20p11.23,recessive,childhood,MtDNA Depletion Syndrome 11; Early-onset Cerebellar Ataxia
MKS1,17q22,recessive,congenital,JBTS28; Meckel Syndrome 1; Bardet-Biedl Syndrome 13
MLC1,22q13.33,recessive,infancy,Megalencephalic Leukoencephalopathy with Subcortical Cysts
MMACHC,1p34.1,recessive,1st to 4th decade,"Hypergonadotrophic Hypogonadism with Ataxia and CNS; Methylmalonic Aciduria and Homocystinuria, cblC type"
MMADHC,2q23.2,recessive,childhood to teens,"Methylmalonic aciduria, cblD type, variant 2; Methylmalonic aciduria and homocystinuria, cblD type; Homocystinuria, cblD type, variant 1"
MME,3q25.2,dominant,42 to 68 years,SCA43; CMTD2T
MORC2,22q12.2,dominant,childhood,"CMTD2Z; Cerebellar Ataxia, Axonal Polyneuropathy with Noctural Hypoventilation"
MPDU1,17p13.1,recessive,congenital,"Congenital disorder of glycosylation, type If"
MPV17,2p23.3,recessive,childhood,Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)
MPZ,1q23.3,dominant and recessive,congenital to early adult,dominant CMTDID; dominant CMTD1B; dominant CMTD2I; dominant CMTD2J; dominant and recessive Dejerine-Sottas Disease
MRE11,11q21,recessive,childhood,Ataxia Telangectasia-like Disorder 1
MRE11A,11q21,recessive,childhood,Ataxia-telangiectasia-like Disorder
MSTO1,1q22,dominant and recessive,childhood to adult,Mitochondrial Myopathy and Ataxia
MTFMT,15q22.31,recessive,childhood,Combined oxidative phosphorylation deficiency 15
MTMR2,11q21,recessive,childhood,CMTD4B1
MTPAP,10p11.23,recessive,early childhood,Spastic Ataxia 4
MTTP,4q23,recessive,teen to early adult,A-beta-lipoproteinemia
MVK,12q24.11,recessive,infancy,Mevalonic Aciduria
NALCN,13q33.1,dominant and recessive,infancy,"dominant Congenital Contractures of the Limbs and Face, Hypotonia, and DD; dominant Cerebellar Ataxia with ID and Arthrogryposis; recessive Infantile Hypotonia with Psychomotor Retardation"
NAT8L,4p16.3,recessive,childhood,?N-acetylaspartate deficiency
NAXE,1q22,recessive,1-2 years,"Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy"
ND1,Mt,maternal,childhood to adult,Mt Complex Deficiency I; Leber Optic Atrophy; Adult-onset Dystonia
ND5,Mt,maternal,childhood to adult,Mt Complex Deficiency I; Leber Optic Atrophy; Melas Syndrome
NDUFA1,Xq24,dominant,infancy,Mitochondrial Complex I Deficiency
NDUFA10,2q37.3,recessive,infancy to early childhood,Leigh syndrome
NDUFA11,19p13.3,recessive,infancy,Mitochondrial Complex I Deficiency
NDUFA12,12q22,recessive,childhood,Leigh syndrome due to mitochondrial complex 1 deficiency
NDUFA2,5q31.3,recessive,childhood,Leigh syndrome due to mitochondrial complex I deficiency
NDUFA9,12p13.32,recessive,childhood,Leigh syndrome due to mitochondrial complex I deficiency
NDUFAF1,15q15.1,recessive,infancy,Mitochondrial Complex I Deficiency
NDUFAF2,5q12.1,recessive,infancy,Mitochondrial Complex I Deficiency
NDUFAF3,3p21.31,recessive,infancy,Mitochondrial Complex I Deficiency
NDUFAF4,6q16.1,recessive,infancy,Mitochondrial Complex I Deficiency
NDUFAF5,20p12.1,recessive,infancy,Mitochondrial Complex I Deficiency
NDUFAF6,8q22.1,recessive,childhood,Leigh syndrome due to mitochondrial complex I deficiency
NDUFB11,Xp11.3,dominant,infancy,Mitochondrial Complex I Deficiency
NDUFB3,2q33.1,recessive,infancy,Mitochondrial Complex I Deficiency
NDUFB9,8q24.13,recessive,infancy,Mitochondrial Complex I Deficiency
NDUFS1,2q33.3,recessive,infancy,Mitochondrial Complex I Deficiency
NDUFS2,1q23.3,recessive,infancy,Mitochondrial Complex I Deficiency
NDUFS3,11p11.2,recessive,infancy,Mitochondrial Complex I Deficiency
NDUFS4,5q11.2,recessive,infancy,Mitochondrial Complex I Deficiency
NDUFS6,5p15.33,recessive,infancy,Mitochondrial Complex I Deficiency
NDUFS7,19p13.3,recessive,childhood,Leigh syndrome
NDUFS8,11q13.2,recessive,childhood,Leigh syndrome
NDUFV1,11q13.2,recessive,infancy,Mitochondrial Complex I Deficiency
NDUFV2,18p11.22,recessive,infancy,Mitochondrial Complex I Deficiency
NECAP1,12p13.31,recessive,infancy,EIEE21
NEFL,8p21.2,dominant and recessive,<13 years,dominant and recessive CMTD1F; dominant CMTD2E; dominant CMTDIG
NEU1,6p21.33,recessive,cildhood to young adult,Sialidosis Type I and II
NF2,22q12.2,dominant,mean 20 years,"Neurofibromatosis, type 2"
NHLRC1,6p22.3,recessive,14 to 27 years,"Epilepsy, progressive myoclonic 2B (Lafora)"
NIPA1,15q11.2,dominant,10 to 35 years,SPG6
NKX2-1,14q13.3,dominant,childhood,"Hereditary Benign Chorea; Choreoanthetosis, Hypothroidism, and Neonatal Respiratory Distress"
NKX6-2,10q26.3,recessive,early childhood,"Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy"
NOL3,16q22.1,dominant,20's to 70's,Familial Cortical Myoclonus
NOP56,20p13,dominant,5th decade,SCA36
NPC1,18q11.2,recessive,childhood to adult,Niemann-Pick Disease C1 and D
NPC2,14q24.3,recessive,infancy,"Niemann-pick disease, type C2"
NPHP1,2q13,recessive,congenital,JBTS4; Juvenile Nephronophthisis 1; Senior-Loken Syndrome 1
NSD1,5q35.3,dominant,adult,SCA; Sotos Syndrome
NT5C2,10q24.32,recessive,infancy to 18 months,SPG45
NTRK2,9q21.33,dominant,infancy,EIEE58
NUBPL,14q12,recessive,2 years,Mitochondrial Complex I Deficiency
NUP62,19q13.33,recessive,infancy,"Striatonigral degeneration, infantile"
OFD1,Xp22.2,recessive,congenital,JBTS10; Retinitis Pigmentosa 23; Simpson-Golabi-Behmel Syndrome 2
OPA1,3q29,dominant,18 to 35 years,Optic Atrophy 1; Optic Atrophy Plus Syndrome; Behr Syndrome
OPA3,19q13.32,dominant and recessive,,"dominant Optic Atrophy 3 with Cataract; recessive 3-Methylglutaconic Aciduria Type III; Optic Atrophy, Cataracts, Lipodystrophy and Peripheral Neuropathy "
OPHN1,Xq12,recessive,congenital,"Mental retardation, X-linked, with cerebellar hypoplasia anddistinctive facial appearance"
OSGEP,14q11.2,recessive,infancy,Galloway-Mowat Syndrome 3 (GAMOS3)
OTC,Xp21.1,recessive,congenital,Ornithine Carbamoyltransferase Deficiency
OTUD4,4q31.21,recessive,adult,Gordon Holmes syndrome (ataxia and hypogonadism)
PAFAH1B1,17p13.3,recessive,congential,Lissencephaly 1; Subcortical Laminar Heterotopia
PAH,12q23.2,recessive,50s to 60's,Phenylketonuria; Adult-onset Spastic Paraparesis and Dementia
PANK2,20p13,recessive,teens to 20's,Neurodegeneration with brain iron accumulation 1; HARP syndrome
PAX6,11p13,dominant,varied,Numerous Optic Symptoms
PC,11q13.2,recessive,infancy,Pyruvate carboxylase deficiency
PCDH19,Xq22.1,germline imprinted,infancy,EIEE9
PCNA,20p13-12,recessive,childhood,Ataxia Telangectasia-like Disorder 2
PDE2A,11q13.4,recessive,childhood,Early-onset Chorea
PDE6D,2q37.1,recessive,congenital,JBTS22
PDGFB,22q13.1,dominant,early to late adult,dominant Idiopathic Basal Ganglia Calcification 5; dominant SIS-related Meningioma
PDGFRB,5q32,dominant,early to late adult,dominant Idiopathic Basal Ganglia Calcification; dominant Infantile Myofibromatosis 1; dominant Kosaki Overgrowth Syndrome
PDHA1,Xp22.12,dominant,early childhood,Pyruvate Dehydrogenase E1-alpha Deficiency
PDHB,3p14.3,recessive,infancy,Pyruvate dehydrogenase E1-beta deficiency
PDSS1,10p12.1,recessive,infancy,"Coenzyme Q10 deficiency, primary, 2"
PDSS2,6q21,recessive,infancy,"Coenzyme Q10 deficiency, primary, 3"
PDYN,20p13-12,dominant,43 to 73 years,SCA23
PET100 ,19p13.2,dominant,congenital,Mitochondrial complex IV deficiency 
PEX1,7q21.2,recessive,infancy,Peroxisome Biogenesis Disorder 1A and 1B; Heimler Syndrome 1
PEX10,1p36.32,recessive,5-6 years,Peroxisome Biogenesis Disorder 6A (Zellweger); Peroxisome Biogenesis Disorder 6B; Ataxia with Motor Neuropathy
PEX12,17q12,recessive,congenital,Peroxisome Biogenesis Disorder 3A and 3B
PEX2,8q21.13,recessive,congenital,Peroxisome Biogenesis Disorder 5A
PEX26,22q11.21,recessive,congenital,Peroxisome Biogenesis Disorder 7A
PEX5,12p13.31,recessive,congenital,"Peroxisomal Biogenesis Disorder 2A and 2B; Rhizomelic Chondrodysplasia Punctata, type 5"
PEX6,6p21.1,dominant and recessive,congenital,Peroxisomal Biogenesis Disorder 4A and 4B; Heimler Syndrome 2
PEX7,6q23.3,recessive,infancy,"Rhizomelic chondrodysplasia punctata, type 1; Peroxisome biogenesis disorder 9B"
PGAP1,2q33.1,recessive,4 months to 4 years,SPG67
PGK1,Xq21.1,recessive,childhood to adult,Phosphoglycerate kinase 1 deficiency
PGM3,6q14.1,recessive,infancy,Immunodeficiency 23
PHYH,10p13,recessive,1st to 3rd decade,Refsum disease
PIBF1,13q21-3,recessive,congenital,JBTS33
PIEZO2,18p11.22,dominant or recessive,1 to 8 years; congenital,"recessive Arthrogryposis, distal, with impaired proprioception and touch; dominant Distal Arthrogryposis Types 3 and 5; Marden-Walker Syndrome"
PIGG,4p16.3,recessive,infancy,"Mental retardation, autosomal recessive 53"
PIGP,21q22.13,recessive,infancy,EIEE55
PIK3R5,17p13.1,recessive,12-18 years,Ataxia with Oculomotor Apraxia 3 (AOA3)
PITRM1,10p15.2,recessive,childhood,Ataxia with ID
PLA2G6,22q13.1,recessive,early childhood,Neurodegeneration with Brain Iron Accumulation 2B; Infantile Neuroaxonal Dystrophy 1; Parkinsons 14
PLCB1,20p12.3,recessive,infancy,EIEE12
PLD3,19q13.2,dominant,35 to 69 years,SCA46
PLP1,Xq22.2,recessive,infancy to childhood,SPG2; Pelizaeus-Merzbacher Disease
PMCA2,3p25.3,dominant,childhood,Ataxia without Deafness
PMM2,16p13.2,recessive,congenital,Congenital Disorder of Glycosylation 2A
PMP22,17p12,dominant and recessive,congenital to early adult,dominant CMTD1A; dominant CMTD1B; dominant Recurrent Neuropathy with Pressure Palsies; dominant and recessive Dejerine-Sottas Disease
PMPCA,9q34.3,recessive,<2 years,SCAR2; Cerebellar Ataxia
PNKD,2q35,dominant,infancy to early teens,Paroxysmal nonkinesigenic dyskinesia
PNKP,19q13.33,recessive,1-9 (mean 4.3),"Ataxia with Oculomotor Apraxia 4 (AOA4); Microcephaly, Seizures and ID"
PNP,14q11.2,recessive,infancy to early childhood,Immunodeficiency due to purine nucleoside phosphorylase deficiency
PNPLA6,19p13.2,recessive,childhood <8 years,Spastic Paraplegia with Distal Arm and Leg Wasting (SPG39); Pure Cerebellar Ataxia; Boucher-Neuhauser syndrome; Oliver-McFarlane syndrome; ?Laurence-Moon syndrome
POLG,15q26.1,recessive,16 to 38 years,Hereditary Sensory Neuropathy and Ophthalmoplegia (SANDO); Pure Progressive Ataxia and Palatal Tremor (PAPT)
POLG2,17q23.3,dominant,adult,"Progressive External Ophthalmoplegia with Mt DNA deletions; Sensory Neuropathy, Ataxia, and Parkinsonism"
POLR1A,2p11.2,recessive,childhood,"Ataxia, Psychomotor Retardation, Cerebellar and Cerebral Atrophy, and Leukodystrophy"
POLR1C,6p21.1,recessive,childhood,HLD11; Treacher-Collins Syndrome 3
POLR3A,10q22.3,recessive,1 to 5 years,Tremor Ataxia with Central Hypomyelinatiing Leukodystrophy 7
POLR3B,12q23.3,recessive,>1 year,Hypomyelinating Leukodystrophy 8; 4H Syndrome
POMGNT1,1p34.1,recessive,congenital,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3; Musculardystrophy-dystroglycanopathy (limb-girdle), type C, 3"
POMGNT2,3p22.1,recessive,congenital,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8"
POMT1,9q34.13,recessive,congenital,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1; Musculardystrophy-dystroglycanopathy (limb-girdle), type C, 1"
POMT2,14q24.3,recessive,congenital,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2; Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2; Musculardystrophy-dystroglycanopathy (limb-girdle), type C, 2"
PPP2R2B,5q32,dominant,8 to 55 years,SCA12
PPT1,1q34.2,recessive,childhood,Neuronal Ceroid Lipofuscinosis 1
PRDM8,4q21.21,recessive,childhood,Progressive Myoclonic Epilepsy 8
PRF1,10q22.1,recessive,childhood to teens,Hemophagocytic Lymphohistiocystosis 2
PRICKLE1,12q12,recessive,4-5 years,Progressive Myoclonus Epilepsy-Ataxia Syndrome; Progressive Myoclonic Epilepsy type 1B (EPM1B)
PRICKLE2,3p14.1,recessive,childhood,Progressive Myoclonic Epilepsy 5
PRKCG,19q13.42,dominant,10 to 59 years,SCA14
PRKRA,2q31.2,recessive,teens,Dystonia 16
PRNP,20p13,dominant,40's,"Cerebral amyloid angiopathy,ÊPRNP-related; Creutzfeldt-Jakob disease; Gerstmann-Straussler disease; Huntington disease-like 1"
PRPS1,Xq22.3,recessive,1-2 years,CMTD5; Arts Syndrome
PRRT2,16p11.2,dominant,infantile to childhood,Infantile Benign Familial Seizures 2; Episodic Kinesigenic Dyskinesia 1; Infantile Familial Convulsions with Paroxysomal Choreoanthetosis
PRX,19q13.2,dominant and recessive,congenital to early adult,recessive CMTD4F; dominant and recessive Dejerine-Sottas Disease
PSAP,10q22.1,recessive,childhood,Metachromatic Leukodystrophy due to SAP-b Deficiency;  Combined SAP deficiency; Atypical Gaucher Disease
PSEN1,14q24.2,dominant,adult,Frontotemporal Dementia; Pick Disease; Alzheimer Disease Type 3 with Spastic Paraparesis and Apraxia or with Unusual Plaques
PTEN,10q23.31,dominant,infancy,Bannayan-Riley-Ruvalcaba syndrome; Cowden syndrome 1; Lhermitte-Duclos syndrome; Meningioma
PTRH2,17q23.1,recessive,infancy,"Multisystem Neurologic, Endocrine, and Pacreatic Disease; Sensorineural Deafness and Peripheral Neuropathy"
PTS,11q23.1,recessive,infancy,Hyperphenylalanemia BH-4 Deficient
PUM1,1p35.2,dominant,adult,"SCA47; Pumilio1-associated DD, Ataxia, and Seizure (PADDAS)"
PYCR2,1q42.12,recessive,infancy,HLD10
QARS,3p21.31,recessive,congenital,"Progressive Microcephaly, Seizures, and Cerebral and Cerebellar Atrophy"
RAB3GAP2,1q41,recessive,6 months,SPG69
RARS,5q34,recessive,infancy,HLD9
RARS2,6q15,recessive,congenital,Pontocerebellar Hypoplasia Type6
REEP1,2p11.2,recessive,teens and 20's,SPG31
REEP2,5q31.2,dominant or recessive,<5,SPG72
RELN,7q22.1,dominant or recessive,childhood to adult,dominant Familial Temporal Lobe Epilepsy 7; recessive Lissencephaly 2
RFT1,3p21.1,recessive,congenital,"Congenital disorder of glycosylation, type In"
RHOBTB2,8p21.3,dominant,congenital,Rett-like Syndrome
RNASEH1,2p25.3,recessive,20's to 40's,"Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2"
RNASET2,6q27,recessive,infancy,"Leukoencephalopathy, cystic, without megalencephaly"
RNF168,3q29,recessive,childhood to teens,RIDDLE syndrome
RNF170,8p11.21,dominant,28 to 55 years,"Ataxia, sensory, 1, autosomal dominant"
RNF216,7p22.1,recessive,childhood to early adult,Cerebellar Ataxia with Hypogonadotropic Hypogonadism
RNU12,22q13.2,recessive,childhood to early adult,Cerebellar Ataxia
ROGDI,16p13.3,recessive,infancy to early childhood,Kohlschutter-Tonz syndrome
RORA,15q22.2,dominant,,ID with Ataxia
RPGRIP1L,16q12.2,recessive,congenital,JBTS7; Meckel Syndrome 5; COACH Syndrome
RPL10,Xq28,recessive,congenital,Syndromic Mental Retardation 35; ID with Epilepsy
RRM2B,8q22.3,dominant and recessive,>2nd decade,dominant Progressive Ophthalmoplegia with DNA Deletions 5; recessive MtDNA Depletion Syndromes 8A and 8B
RTN2,19q13.32,dominant,5 to 39 years,SPG12
RTN4IP1,6q21,recessive,40's to 50's,optic atrophy-10 (OPA10)
RUBCN,3q29,recessive,<1 year,SCAR15; Ataxia with Epilepsy and Mental Retardation
SACS,13q12.12,recessive,1 to 20 (mean 4),Charlevoix-Saquenay Spastic Ataxia (ARSACS; SPAX6)
SAMD9L,7q21.2,dominant,early childhood to 62,Ataxia pancytopenia syndrome
SARS,1p13.3,recessive,infancy,"Neurodevelopmental Disorder with Microcephaly, Ataxia, and Seizures"
SCARB2,4q21.1,recessive,teens,Progressive Myoclonic Epilepsy type 4; Myoclonus Epilepsy and Demyelinating Polyneuropathy
SCN10A,3p22.2,dominant ,childhood to adult,Episodic Pain Syndrome 2
SCN11A,3p22.2,dominant,childhood,Hereditary Sensory and Autonomic Neuropathy type VII; Familial Episodic Pain Syndrome 3
SCN1A,2q24.3,dominant,<6 months,Early Infantile Epileptic Encephalopathy type 6 (EIEE6; Dravet syndrome); Familial febrile seizures 3A; Familial hemiplegic migraine 3
SCN1B,19q13.3,dominant and recessive,infancy,recessive EIEE52; dominant Generalized Epilepsy with Febrile Seizures Type 1
SCN2A,2q24.3,dominant,infancy,EIEE11; Benign Familial Infantile Seizures; Neonatal Seizures Followed by Ataxia in Toddlers; late-onset EA
SCN3A,2q24.3,dominant,infancy,EIEE62; Familial Focal Epilepsy with Variable Foci 4
SCN4A,17q23.2,dominant,congenital,Congenital Myotonia; Congenital Paramyotonia; Hypo and Hyperkalemic Periodic Paralysis 2
SCN8A,12q13.13,dominant,infancy,Cognitive Impairment with or without Cerebellar Ataxia; EIEE13; Benign Familial Infantile Seizures 5
SCN9A,2q24.3,dominant and recessive,childhood to adult,Small Fiber Neuropathy; Familial Febrile Seizures 3B; Epilepsy with Febrile Seizures 7; recessive HSAN2D
SCO1 ,17p13.1,dominant,congenital,Mitochondrial complex IV deficiency 
SCYL1,11q13.1,recessive,1-3 years,SCAR21; Hepatocerebellar Neuropathy
SDHA,5p15.33,dominant and recessive,childhood to adult,dominant Paragangliomas 5; recessive Mt Respiratory Chain Complex II Deficiency
SDHAF1,19q13.12,recessive,childhood to 20's,Mitochondrial complex II deficiency
SDHD ,11q23.1,dominant or recessive,childhood to 20's,recessive Mitochondrial complex II deficiency; dominant Paraganglioma 1; dominant Pheochromocytoma 
SEPSECS,4p15.2,recessive,congenital,Pontocerebellar Hypoplasia2D
SETX,9q34.13,dominant and recessive,2nd decade,dominant Juvenile-onset ALS4; recessive Ataxia with Oculomotor Apraxia 2 (AOA2)
SGCE,7q21.3,dominant,1st to 2nd decade,Myoclonic Dystonia 11
SGPL1,10q22.1,recessive,11 and 12 years,Nephrotic Syndrome 14
SH3TC2,5q32,dominant or recessive,2 to 10 years; early adulthood,"recessive CMTD4C; dominant Mononeuropathy ofthe median nerve, mild"
SHROOM4,Xp11.22,recessive,congenital,Stocco dos Santos X-linked Mental Retardation Syndrome
SIK1,21q22.3,dominant,infancy,EIEE30
SIL1,5q31.2,recessive,infancy,Marinesco-Sjogren Syndrome
SLC12A5,20q13.12,recessive,infancy,EIEE34
SLC13A5,17p13.1,recessive,infancy,EIEE25
SLC16A2,Xq13.2,dominant,congenital,SPG22; Allan-Herndon-Dudley Syndrome
SLC17A5,6q13,recessive,1-2 years,Salla Disease; Infantile Sialic Acid Storage Disease
SLC19A2,1q24.2,recessive,1 to 11 years,Thiamine-responsive megaloblastic anemia syndrome
SLC19A3,2q36.3,recessive,1 to 14 years,Thiamine metabolism dysfunction syndrome 2 (biotin- orthiamine-responsive encephalopathy type 2)
SLC1A2,11p13,dominant,infancy,EIEE41
SLC1A3,5p13.2,dominant,infant to 3 years,Episodic Ataxia 6 (EA6)
SLC1A4,2p14,recessive,congenital,Spastic tetraplegia; Thin Corpus Callosum and Progressive Microcephaly
SLC20A2,8p11.21,dominant,30 to 50 years,Idiopathic Basal Ganglia Calcification 1; Ataxia with High Cerebrospinal Fluid Phosphate
SLC25A1,22q11.21,recessive,congenital,D-2 and L-2 Hydroxyglutaric Aciduria
SLC25A12,2q31.1,recessive,infancy,EIEE39
SLC25A2,5q31.3,recessive,childhood,Spinocerebellar Ataxia with Blindness and Deafness 2 (SCABD2)
SLC25A22,11p15.5,recessive,infancy,EIEE3
SLC25A32,8q22.3,recessive,childhood,"Childhood-onset Dystonia and Adult-onset Dysarthria, Swallowing Difficulties and Ataxia"
SLC25A46,5q22.1,recessive,childhood to adult,Hereditary Motor and Sensory Neuropathy Type VIB; CMTD2; Cerebellar Ataxia
SLC2A1,1p34.2,dominant,infantile to childhood,Dystonia 9; GLUT1 Deficiency Syndrome 1 and 2; Stomatin-deficient Cryohydrocytosis with Neurologic Defects
SLC30A10,1q41,recessive,14 years,"Paraparesis, Hypermanganesemia, Polycythaemia and Cirrohsis"
SLC30A9,4p13,recessive,congenital,Cerebro-Renal syndrome; Birk-Landau-Perez syndrome
SLC33A1,3q25.31,dominant,4 to 40 years,SPG42
SLC35A2,Xp11.23,dominant,infancy,Congenital Disorder of Glycosylation Iim; EIEE22
SLC39A4,8q24.3,recessive,infancy,Acrodermatitis enteropathica
SLC46A1,17q11.2,recessive,infancy to early childhood,"Folate malabsorption, hereditary"
SLC52A2,8q24.3,recessive,8 to 9 years,"SCAR3, Spinocerebellar Ataxia with Blindness and Deafness (SCABD)"
SLC52A3,20p13,recessive,infancy to early teens,Brown-Vialetto-Van Laere syndrome 1; Fazio-Londe Disease
SLC6A1,3p25.3,dominant,1 to 4 years,Myoclonic-atonic epilepsy
SLC6A19,5p15.33,dominant and recessive ,adult (30-40s),dominant Hyperglycinuria; recessive Hartnup Disorder
SLC6A2,16q12.2,dominant,15-50 (mean 29),Postural Orthostatic Tachycardia Syndrome (POTS)
SLC9A1,1p36.11,recessive,<2 years,SCAR19; Lichtenstein-Knorr syndrome
SLC9A6,Xq26.3,dominant,congenital,X-linked Syndromic ID
SMARCA1,Xq25-26,dominant,congenital,Rett-like Syndrome
SMARCA4,19p13.2,dominant,congenital,Mental Retardation 16 (MRD16)
SNAP25,20p12.1,dominant,congenital,Myasthenic Syndrome
SNCA,4q22.1,dominant,adult - 65,"Lewy body dementia, Parkinsons 1, Parkinsons 4"
SNCB,5q35.2,dominant,adult - 65,Lewy body dementia
SNX14,6q14.3,recessive,<1 year,SCAR20; Ataxia with Mental Retardation
SOD1,21q22.11,dominant or recessive,adulthood,dominant or recessive Amyotrophic lateral sclerosis 1
SOX10,22q13.1,dominant,congenital,PCWH Syndrome; Waardenburg Syndrome 2E with or without Neurologic Involvement; Waardenburg Syndrome 4C
SPART,13q13.3,recessive,early childhood,SPG20; Troyer Syndrome
SPAST,2p22.3,dominant,infancy to 63 years,SPG4
SPEG,2q35,recessive,congenital,Centronuclear myopathy 5
SPG11,15q21.1,recessive,20's,Spastic paraplegia 11; CMTD2X; Juvenile ALS 5
SPG7,16q24.3,dominant and recessive,1st to 5th decade (mean 36),SPG7; SPG5C; Spastic Ataxia
SPR,2p13.2,dominant or recessive,infancy to early adult,"dominant or recessive Dystonia, dopa-responsive, due to sepiapterin reductase deficiency"
SPTAN1,9q34.11,dominant,infancy,EIEE5
SPTBN2,11q13.2,dominant and recessive,early childhood,SCA5; SCAR14; Infantile-onset Spinocerebellar Ataxia with Psychomotor Delay
SQSTM1,5q35.3,recessive,childhood; adult to late adult; adult; adult,"Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset; dominant Frontotemporal dementia and/or ALS 3; dominant Myopathywith rimmed vacuoles; dominant Paget disease of bone"
ST3GAL3,1p34.1,recessive,infancy,EIEE15
STUB1,16p13.3,recessive,2 to 49 years,SCAR16; Ataxia with or without Hypogonadism or Spacticity
STXBP1,9q34.11,dominant,infancy,EIEE4; Ataxia-Tremor-Retardation Syndrome
SUCLA1,2p11.2,recessive,childhood,"MtDNA Depletion Syndrome 9; Psychomotor Delay, Deafness, Myopathy, Ataxia, and Chorea"
SUCLG1,2p11.2,recessive,infancy,Mitochondrial DNA depletion syndrome 9 (encephalomyopathic typewith methylmalonic aciduria)
SUFU,10q24.32,dominant and recessive,congenital ,dominant Basal Cell Nevus Syndrome; dominant Desmoplastic Medulloblastoma; recessive Joubert Syndrome type 32; recessive Desmoplastic Medulloblastoma
SULT4A1,22q13.31,recessive,mouse,"Tremor, Absence Seizures, Abnormal Gait, and Ataxia"
SUMF1,3p26.1,recessive,infancy to very early childhood,Multiple sulfatase deficiency
SUOX,12q13.2,recessive,infancy to childhood,Sulfite oxidase deficiency
SURF1,9q34.2,recessive,infancy to early childhood; 1st decade,"Leigh syndrome, due to COX deficiency; CMTD4K"
SYNE1,6q25.1-2,recessive,17-46 (mean 30),Pure cerebellar ataxia 1 (SCAR1; Beauce ataxia)
SYNJ1,21q22.11,recessive,infancy,EIEE53
SYT14,1q32.2,recessive,ID childhood - ataxia 60,SCAR11; ARCA; Cerebellar ataxia with Psychomotor Retardation
SZT2,1p34.2,recessive,infancy,EIEE18
TACO1 ,17q23.3,dominant,infancy,Mitochondrial complex IV deficiency; Leigh Syndrome due to COX4 Deficiency
TAF1,Xq13.1,recessive,12 to 56 years,Dystomia-Parkinsonism; Syndromic Mental Retardation 33
TBC1D23,3q12.1,recessive,childhood to teens,Pontocerebellar Hypoplasia 11
TBC1D24,16p13.3,dominant and recessive,infancy,dominant Deafness 65; recessive Deafness 86; recessive DOORS; recessive EIEE16; recessive Myoclonic Epilepsy
TBCE,1q42.3,recessive,6 to 20 years;infancy to very early childhood; congenital,"Encephalopathy, progressive, with amyotrophy and optic atrophy; Hypoparathyroidism-retardation-dysmorphism syndrome; Kenny-Caffey syndrome, type 1"
TBK1,12q14.2,dominant,adult,Frontotemporal Dementia and/or Amyotrophic Lateral Sclerosis 4; Acute Infection Induced Encephalopathy
TBP,6q27,dominant,10 to 80 (mean 30's),SCA17
TCF4,18q21.2,dominant,early childhood,Pitt-Hopkins syndrome
TCN2,22q12.2,recessive,infancy,Transcobalamin II deficiency
TCTN1,12q24.11,recessive,congenital,JBTS13
TCTN2,12q24.31,recessive,congenital,JBTS24; Meckel Syndrome 8
TCTN3,10q24.1,recessive,congenital,JBTS18; Orofaciodigital Syndrome IV
TDP1,14q32.11,recessive,13-15 years,Spinocerebellar Ataxia with Axonal Neuropathy (SCAN1)
TDP2,6p22.3,recessive,1-12 years,SCAR23; Ataxia with Epilepsy and Mental Retardation
TECPR2,14q32.31,recessive,<2 years,SPG49; Spastic Paraplegia Complex with Thin Corpus Callosum
TELO2,16p13.3,recessive,infancy,Yoo-Hoover-Fong syndrome
TFG,3q12.2,dominant or recessive,adult; childhood,dominant Hereditary Motor and Sensory Neuropathy; recessive SPG57
TGM6,20p13,dominant,5th decade,SCA35
TH,11p15.5,recessive,infancy,"Segawa syndrome, recessive"
THAP1,8p11.21,dominant,late teens,Torsion Dystonia 6
THG1L,5q33.3,recessive,1 to 8 years,Cerebellar Ataxia with DD
TIMMDC1,3q13.33,recessive,infancy,Mitochondrial Complex I Deficiency
TINF2,14q12,dominant,10 to 31 years; infancy to very early childhood,"Dyskeratosis congenita, autosomal dominant 3; Revesz syndrome"
TK2,16q21,recessive,childhood,Myopathic Mitochondrial DNA Depletion Syndrome 2
TMEM106B,7p21.3,recessive,infancy,HLD16
TMEM107,17p13.1,recessive,congenital,JBTS29; Meckel Syndrome 13; Orofaciodigital Syndrome XVI
TMEM126B,11q14.1,recessive,infancy,Mitochondrial Complex I Deficiency
TMEM138,11q12.2,recessive,congenital,JBTS16
TMEM216,11q12.2,recessive,congenital,JBTS2; Meckle Syndrome type 2
TMEM231,16q23.1-2,recessive,congenital,JBTS20; Meckel Syndrome 11
TMEM237,2q33.1,recessive,congenital,JBTS14
TMEM240,1p36.33,dominant,2-20 years,SCA21
TMEM67,8q22.1,recessive,congenital,JBTS6; Meckel Syndrome 3; Nephronophthisis 11; COACH Syndrome 
TMEM70,8q21,recessive,infancy,Mt Complex V
TOE1,1p34.1,recessive,congenital,Pontocerebellar Hypoplasia 7
TOR1A,9q234.11,dominant,4 to 44 years (mean 14),Torsion Dystonia 1
TP53RK,20q13.12,recessive,<1 year,Galloway-Mowat Syndrome 4 (GAMOS4)
TPK1,7q35,recessive,1 to 4 years,Thiamine Metabolism Dysfunction Syndrome 5
TPP1,11p15.4,recessive,early childhood,SCAR7; Neuronal Ceroid Lipofuscinosis 2
TRAPPC11,4q35.1,recessive,childhood,Limb Girdle Muscular Dystrophy Type 25
TRIM2,4q31.3,recessive,<1 year,CMTD2R
TRNT1,3p26.2,recessive,infancy; 20's,"Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay; Retinitis pigmentosa and erythrocytic microcytosis "
TRPC3,4q27,dominant,38 years,SCA41
TSEN15,1q25.3,recessive,congenital,Pontocerebellar Hypoplasia2F
TSEN2,3p25.2,recessive,congenital,Pontocerebellar Hypoplasia2B
TSEN34,19q13.42,recessive,congenital,Pontocerebellar Hypoplasia2C
TSEN54,17q25.1,recessive,congenital,"Pontocerebellar Hypoplasia2A, 4 and5"
TSFM,12q14.1,recessive,infancy,Combined oxidative phosphorylation deficiency 3
TSGA14,7q32,recessive,congenital,JBTS15
TTBK2,15q15.2,dominant,25 to 40 years,SCA11
TTC19,17p12,recessive,5 to 42 years,Mt Complex III Deficiency 2
TTC21B,2q24.3,dominant and recessive,congenital,JBTS11; Nephronophthisis 12
TTPA,8q12.3,recessive,childhood,Ataxia with Vit E Deficiency
TTR,18q12.1,dominant,17 to 78 (mean 35),"Amyloidosis, hereditary, transthyretin-related; [Dystransthyretinemic hyperthyroxinemia]; Carpal tunnel syndrome, familial"
TUBA1A,12q13.12,dominant,childhood,Lissencephaly 3
TUBB,6p21.33,dominant,childhood,"Cortical dysplasia, complex, with other brain malformations 6; Symmetric circumferential skin creases, congenital, 1"
TUBB2A,6p25.2,dominant,childhood to early adult,Cortical Dysplasia with Other Brain Abnormalities; Spastic Ataxia Syndrome
TUBB4A,19p13.3,dominant,infancy,Leukoencephalopathy; HLD6; Whispering Dystonia
TWNK,10q24.31,recessive,1 to 2 years,Infantile-onset Spinocerebellar Ataxia (IOSCA); Mitochondrial DNA Depletion Syndrome 7 (hepatocerebral type)
TYMP,22q13.33,recessive,20's to 40's,Mitochondrial DNA depletion syndrome 1 (MNGIE type)
UBA5,3q22.1,recessive,5 to 8 years,SCAR24; Ataxia with Cataracts; Early Infantile Epileptic Ecephalopathy 44 (EIEE44)
UBE3A,15q11.2,isolated cases,1-3 years,Angelman Syndrome
UBR4,1p36.13,dominant,childhood,Episodic Ataxia (EA8)
UCHL1,4p13,recessive,5 to 10 years,SPG79; Neurodegeneration with Optic Atrophy
UNC80,2q34,recessive,infancy,Infantile Hypotonia with Psychomotor Retardation and Characteristic Facies 2
UQCRB,8q22.1,recessive,infancy,"Mitochondrial complex III deficiency, nuclear type 3  "
UQCRQ,5q31.1,recessive,infancy,"Mitochondrial complex III deficiency, nuclear type 4  "
UROC1,3q21.3,recessive,childhood to early adult,Urocanase deficiency
USP8,15q21.2,recessive,1-2 years,SPG59
VAMP1,12p13.31,dominant,childshood to early 20's,Spastic Ataxia 1 (SPAX1)
VARS2,6p21.33,recessive,childhood,Combined Oxidative Phosphorylation Deficiency 20
VCP,9p13.3,dominant,40s to 60's,CMTD2Y; Inclusion Body Myopathy with Early-onset Paget Disease and Frontotemporal Dementia1
VHL,3p25.3,dominant,20's to 50's,von Hippel-Lindau Syndrome; Pheochromocytoma
VLDLR,9p24.2,recessive,congenital,Cerebellar hypoplasia and Mental Retardation with or without Quadrupedal Locomotion 1
VPS11,11q23.3,recessive,infancy to young adult,HLD12
VPS13D,1p36,recessive,childhood,Cerebellar Ataxia
VPS37A,8p22,recessive,1 to 3 years,SPG53; Spastic Paraplegia with Mental Impairment
VPS53,17p13.3,recessive,congenital,Pontocerebellar Hypoplasia2E
VRK1,14q32.2,recessive,congenital,Pontocerebellar Hypoplasia1A
VWA3B,2q11.2,recessive,ID childhood - ataxia adult,SCAR22; Ataxai with Mental Retardation and Pyramidal Features
WARS2,1p12,recessive,infancy,"Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures"
WDR26,1q42.11-12,recessive,infancy,Skraban-Deardorff syndrome
WDR48,3p22.2,recessive,1 year,SPG60
WDR62,19q13.12,recessive,congenital,"Microcephaly 2, primary, autosomal recessive, with or withoutcortical malformations"
WDR73,15q25.2,recessive,congenital,SCAR5; Childhood-onset Cerebellar Ataxia; Galloway-Mowat Syndrome (GAMOS)
WDR81,17p13.3,recessive,congenital,"Cerebellar Ataxia, Mental Retardation, and Dysequilibrium Syndrome 2"
WFS1,4p16.1,recessive,childhood,Wolfram Syndrome
WWOX,16q23.1-2,recessive,1-2 years,SCAR12; Early Infantiale Epileptic Encephalopathy 28 (EIEE28)
XPA,9q22.33,recessive,median age 8,"Xeroderma pigmentosum, group A"
XPC,3p25.1,recessive,childhood,Xeroderma pigmentosum C; Xeroderma pigmentosum with Neurological Manifestation (De Sanctis-Caccione Syndrome
XPR1,1q25.3,dominant,early to late adult,Idiopathic Basal Ganglia Calcification 6
XRCC1,19q13.31,recessive,28 years,SCAR26; Spinocerebellar Ataxia
XRCC4,5q14.2,recessive,childhood to early adult,"Short stature, microcephaly, and endocrine dysfunction"
YARS,1p35.1,dominant,7 to 59 years,CMTDIC
YME1L1,10p12.1,recessive,infancy,Optic Atrophy 11
YWHAG,7q11.23,dominant,infancy,EIEE56
ZFR,5p13.3,recessive,1 year,SPG71
ZFYVE26,14q24.1,recessive,5 to 23 years,SPG15
ZFYVE27,10q24.2,dominant,adult,SPG33
ZIC1,3q24,dominant,congenital,Craniosynostosis 6
ZNF238,1q44,dominant,infancy,Mental Retardation 22; Rett-like Syndrome
ZNF423,16q12.1,dominant or recessive,congenital,JBTS19; Nephronophthisis 14

